European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP).

• Date:
  Antradienis, 01 Balandis 2025 , 09:00 - 17:45 Amsterdam time (CEST)
  Trečiadienis, 02 Balandis 2025 , 09:00 - 15:50 Amsterdam time (CEST)
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP).

Documents

Meeting summary - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting on 1-2 April 2025

Reference Number: EMA/115618/2025

Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting on 1-2 April 2025

Draft Reference Number: EMA/31466/2025

Presentation - EMA's 30th anniversary (E. Cooke)

Presentation - Clinical trials update (P. Arlett)

Presentation - ACT EU workplan 2025-2026 (L. Pioppo)

Presentation - Feedback from ACT EU workshop on ICH E6 R3 (P. Twomey, K. Pietsch and F. Houÿez)

Presentation - Update on Multistakeholder platform (A. Zanoletty)

Presentation - Risk minimisation in healthcare: updates on policy, practice, research and engagement (P. Bahri)

Presentation - Update on EMA policy on competing interests (policy 0044) (Z. Hanaizi)

Presentation - EMANS to 2028 (M. Carr and R. Santos)

Presentation - Update of the QRD template: revision of the package leaflet (M. Buch)

Presentation - Electronic product information (ePI) pilot and next steps (E. Scanlan)

Presentation - European Patients Forum’s statement (S. Jouan)

Presentation - Joint statement on ePI (D. Teixeira Pereira)

Presentation - Introduction to shortages topic (M. Dias)

Presentation - Transfer of Task Force on Availability of Authorised Medicines for Human and Veterinary Use activities (TF-AAM) and The Working Group of the MSSG on the Vulnerability Assessment Methodology (V. Bennett)

Presentation - Ongoing critical shortages (K. Kruttwig)

Presentation - European Shortages Monitoring Platform (ESMP) update (S. Zastavnik)

Presentation - CAT committee feedback (K. Sollerbrant)

Presentation - COMP committee feedback (I. Alves and J. Rocha)

Presentation - HMPC committee feedback (An Lê)

Presentation - PDCO committee feedback (J. Taminiau)

Presentation - Data Analysis and Real World Interrogation Network (DARWIN EU): Three years of a journey (A. Segec)

Presentation - Update on Patient Experience Data (PED) reflection paper (K. Immonen)

Presentation - Call for PCWP and HCPWP mandate 2025-2028 (M. Bonafonte and I. Silva)

Presentation - Information on election of PCWP and HCPWP co-chairs (M. Mavris)

Presentation - Highlights of PCWP HCPWP 2023-2025 mandate (M. Mavris)

Presentation - Information ecosystem management (R. Gonzalez-Quevedo and S. Labbe)

Presentation - Update on communication campaigns (G. Gabrielli and C. Enachioiu)

Presentation - Cross-agency One Health Task Force (A. Vidal)

Presentation - 10 years of experience of patient involvement EMA, opportunities, challenges and learnings for meaningful patient involvement (E. Vroom, D. Athanasiou)

Presentation - Preparing future roles for patients and HCP in EMA committees PRAC-CHMP (F. Houyez)